Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
50%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
3
33%
Ph early_phase_1
1
11%
Ph phase_4
3
33%
Ph phase_3
2
22%

Phase Distribution

1

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 32 (22.2%)
Phase 43 (33.3%)

Trials by Status

unknown222%
completed667%
terminated111%

Recent Activity

0 active trials
Showing 5 of 9
completedearly_phase_1

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

NCT04075110
unknownphase_2

The Covid-19 Outpatient Symptom Montelukast Oximetry Trial

NCT04389411
terminatedphase_3

Montelukast for Patients With Obstructive Sleep Apnea Syndrome

NCT03545997
completedphase_2

Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans

NCT04374981
unknownphase_3

Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease

NCT04277702
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04075110Early Phase 1

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

Completed
NCT04389411Phase 2

The Covid-19 Outpatient Symptom Montelukast Oximetry Trial

Unknown
NCT03545997Phase 3

Montelukast for Patients With Obstructive Sleep Apnea Syndrome

Terminated
NCT04374981Phase 2

Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans

Completed
NCT04277702Phase 3

Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease

Unknown
NCT03380975Phase 4

Role of Montelukast in Asthma and Allergic Rhinitis Patients

Completed
NCT02761252Phase 4

Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma

Completed
NCT01696214Phase 4

A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial

Completed
NCT01147744Phase 2

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9